Attached files

file filename
EX-32.2 - EX-32.2 - Osmotica Pharmaceuticals plcosmt-20201231ex32258f297.htm
EX-32.1 - EX-32.1 - Osmotica Pharmaceuticals plcosmt-20201231ex321953c24.htm
EX-31.2 - EX-31.2 - Osmotica Pharmaceuticals plcosmt-20201231ex312bc27dd.htm
EX-31.1 - EX-31.1 - Osmotica Pharmaceuticals plcosmt-20201231ex3113fd9c7.htm
EX-23.1 - EX-23.1 - Osmotica Pharmaceuticals plcosmt-20201231ex23112d1d2.htm
EX-10.25 - EX-10.25 - Osmotica Pharmaceuticals plcosmt-20201231ex102511c8a.htm
EX-4.4 - EX-4.4 - Osmotica Pharmaceuticals plcosmt-20201231ex44a3bea72.htm
EX-4.2 - EX-4.2 - Osmotica Pharmaceuticals plcosmt-20201231ex42947309e.htm
10-K - 10-K - Osmotica Pharmaceuticals plcosmt-20201231x10k.htm

Exhibit 21.1

Osmotica Pharmaceuticals plc

Subsidiary

    

State or Other Jurisdiction of Organization

Osmotica Holdings US LLC

Delaware

Osmotica Kereskedelmi es Szolgaltato Kft

Hungary

Osmotica Pharmaceutical Corp.

Delaware

RVL Pharmaceuticals, Inc.

Delaware

Osmotica Argentina, S.A.

Argentina

Valkyrie Group Holdings, Inc.

Delaware

Vertical/Trigen Holdings, LLC(1)

Delaware

Osmotica Pharmaceutical US, LLC

Delaware

Vertical/Trigen Opco, LLC

Delaware

Trigen Laboratories, LLC

Delaware

Vertical Pharmaceuticals, LLC

Delaware


(1)  Vertical/Trigen Holdings, LLC is jointly-owned by Valkyrie Group Holdings, Inc. and Osmotica Pharmaceutical Corp.